Roberto Pili

  • 10771 Citations
  • 51 h-Index
1990 …2019
If you made any changes in Pure, your changes will be visible here soon.

Publications 1990 2019

Article
53 Citations (Scopus)

Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer

Fontana, L., Adelaiye, R. M., Rastelli, A. L., Miles, K. M., Ciamporcero, E., Longo, V. D., Nguyen, H., Vessella, R. & Pili, R., Dec 2013, In : Oncotarget. 4, 12, p. 2451-2461 11 p.

Research output: Contribution to journalArticle

Dietary Proteins
Heterografts
Prostatic Neoplasms
Breast Neoplasms
Diet
3 Citations (Scopus)

Dietary protein restriction reprograms tumor-associated macrophages and enhances immunotherapy

Orillion, A., Damayanti, N. P., Shen, L., Adelaiye-Ogala, R., Affronti, H., Elbanna, M., Chintala, S., Ciesielski, M., Fontana, L., Kao, C., Elzey, B. D., Ratliff, T. L., Nelson, D. E., Smiraglia, D., Abrams, S. I. & Pili, R., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6383-6395 13 p.

Research output: Contribution to journalArticle

Dietary Proteins
Immunotherapy
Macrophages
Neoplasms
Amino Acids
405 Citations (Scopus)

Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth

Zhang, H., Qian, D. Z., Tan, Y. S., Lee, K., Gao, P., Ren, Y. R., Rey, S., Hammers, H., Chang, D., Pili, R., Dang, C. V., Liu, J. O. & Semenza, G. L., Dec 16 2008, In : Proceedings of the National Academy of Sciences of the United States of America. 105, 50, p. 19579-19586 8 p.

Research output: Contribution to journalArticle

Hypoxia-Inducible Factor 1
Cardiac Glycosides
Digoxin
Growth
Neoplasms
23 Citations (Scopus)

Dll4 blockade potentiates the anti-tumor Effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts

Miles, K. M., Seshadri, M., Ciamporcero, E., Adelaiye, R., Gillard, B., Sotomayor, P., Attwood, K., Shen, L., Conroy, D., Kuhnert, F., Lalani, A. S., Thurston, G. & Pili, R., Nov 13 2014, In : PLoS One. 9, 11, e112371.

Research output: Contribution to journalArticle

vascular endothelial growth factors
kidney cells
Renal Cell Carcinoma
Heterografts
Vascular Endothelial Growth Factor A
20 Citations (Scopus)

Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer

Tolcher, A. W., Chi, K. N., Shore, N. D., Pili, R., Molina, A., Acharya, M., Kheoh, T., Jiao, J. J., Gonzalez, M., Trinh, A., Pankras, C. & Tran, N., Aug 2012, In : Cancer Chemotherapy and Pharmacology. 70, 2, p. 305-313 9 p.

Research output: Contribution to journalArticle

Castration
Prednisone
Prostatic Neoplasms
Electrocardiography
Pharmacokinetics
141 Citations (Scopus)

Endogenous reactivation of the RARβ2 tumor suppressor gene epigenetically silenced in breast cancer

Sirchia, S. M., Ren, M., Pili, R., Sironi, E., Somenzi, G., Ghidoni, R., Toma, S., Nicolò, G. & Sacchi, N., May 1 2002, In : Cancer Research. 62, 9, p. 2455-2461 7 p.

Research output: Contribution to journalArticle

Retinoic Acid Receptors
Tumor Suppressor Genes
Breast Neoplasms
Chromatin
DNA Methylation
18 Citations (Scopus)

Endothelial cell Ca2+ increases upon tumor cell contact and modulates cell-cell adhesion

Pili, R., Corda, S., Passaniti, A., Ziegelstein, R. C., Heldman, A. W. & Capogrossi, M. C., 1993, In : Journal of Clinical Investigation. 92, 6, p. 3017-3022 6 p.

Research output: Contribution to journalArticle

Cell Adhesion
Endothelial Cells
Neoplasms
Melanoma
Ethane

Endothelial cell Ca2+ is increased by melanoma cell adhesion

Pili, R., Ziegelstein, R. C., Passaniti, A. & Capogrossi, M. C., 1993, In : Clinical Chemistry and Enzymology Communications. 6, 1-2, p. 79-83 5 p.

Research output: Contribution to journalArticle

Cell adhesion
Endothelial cells
Cell Adhesion
Melanoma
Endothelial Cells
58 Citations (Scopus)

Entinostat neutralizes myeloid-derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell carcinoma

Orillion, A., Hashimoto, A., Damayanti, N., Shen, L., Adelaiye-Ogala, R., Arisa, S., Chintala, S., Ordentlich, P., Kao, C., Elzey, B., Gabrilovich, D. & Pili, R., Sep 1 2017, In : Clinical Cancer Research. 23, 17, p. 5187-5201 15 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Tumor Microenvironment
Lung
Immunosuppressive Agents
Neoplasms
67 Citations (Scopus)

Epigenetic modulation of retinoic acid receptor β2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma

Wang, X. F., Qian, D. Z., Ren, M., Kato, Y., Wei, Y., Zhang, L., Fansler, Z., Clark, D., Nakanishi, O. & Pili, R., May 1 2005, In : Clinical Cancer Research. 11, 9, p. 3535-3542 8 p.

Research output: Contribution to journalArticle

Retinoic Acid Receptors
Histone Deacetylase Inhibitors
Renal Cell Carcinoma
Epigenomics
Isotretinoin
10 Citations (Scopus)

EZH2 modifies sunitinib resistance in renal cell carcinoma by kinome reprogramming

Adelaiye-Ogala, R., Budka, J., Damayanti, N. P., Arrington, J., Ferris, M., Hsu, C. C., Chintala, S., Orillion, A., Miles, K. M., Shen, L., Elbanna, M., Ciamporcero, E., Arisa, S., Pettazzoni, P., Draetta, G. F., Seshadri, M., Hancock, B., Radovich, M., Kota, J., Buck, M. & 9 others, Keilhack, H., McCarthy, B. P., Persohn, S. A., Territo, P. R., Zang, Y., Irudayaraj, J., Tao, W. A., Hollenhorst, P. & Pili, R., Dec 1 2017, In : Cancer Research. 77, 23, p. 6651-6666 16 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Receptor Protein-Tyrosine Kinases
Transferases
Drug Resistance
Heterografts
4 Citations (Scopus)

Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer

Ellis, L., Ku, S. Y., Li, Q., Azabdaftari, G., Seliski, J., Olson, B., Netherby, C. S., Tang, D. G., Abrams, S. I., Goodrich, D. W. & Pili, R., Sep 15 2016, In : Prostate. 76, 13, p. 1192-1202 11 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Cell Line
Tumor Microenvironment
Prostate
Transgenic Mice
9 Citations (Scopus)

Generation of a syngeneic orthotopic transplant model of prostate cancer metastasis

Ellis, L., Lehet, K., Ku, S. Y., Azabdaftari, G. & Pili, R., 2014, In : Oncoscience. 1, 10, p. 609-613 5 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Neoplasm Metastasis
Transplants
Lymph
Androgens
16 Citations (Scopus)

Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts

Wei, L., Chintala, S., Ciamporcero, E., Ramakrishnan, S., Elbanna, M., Wang, J., Hu, Q., Glenn, S. T., Murakami, M., Liu, L., Gomez, E. C., Sun, Y., Conroy, J., Miles, K. M., Malathi, K., Ramaiah, S., Anbarasu, A., Woloszynska-Read, A., Johnson, C. S., Conroy, J. & 3 others, Liu, S., Morrison, C. D. & Pili, R., 2016, In : Oncotarget. 7, 47, p. 76374-76389 16 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinases
Heterografts
Urinary Bladder Neoplasms
Cisplatin
Mutation
11 Citations (Scopus)

HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma

Ramakrishnan, S., Ku, S. Y., Ciamporcero, E., Miles, K. M., Attwood, K., Chintala, S., Shen, L., Ellis, L., Sotomayor, P., Swetzig, W., Huang, R., Conroy, D., Orillion, A., Das, G. & Pili, R., 2016, In : BMC Cancer. 16, 1, 617.

Research output: Contribution to journalArticle

Histone Deacetylases
Renal Cell Carcinoma
Cell Movement
Protein Isoforms
Cell Line
16 Citations (Scopus)

High-dose interleukin-2 therapy for metastatic renal cell carcinoma: A contemporary experience

Hanzly, M., Aboumohamed, A., Yarlagadda, N., Creighton, T., Digiorgio, L., Fredrick, A., Rao, G., Mehedint, D., George, S., Attwood, K., Kauffman, E., Narashima, D., Khushalani, N. I., Pili, R. & Schwaab, T., 2014, In : Urology. 83, 5, p. 1129-1134 6 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Interleukin-2
Kidney
Therapeutics
Disease-Free Survival
11 Citations (Scopus)

Histone modifications: Implications in renal cell carcinoma

Ramakrishnan, S., Ellis, L. & Pili, R., Aug 2013, In : Epigenomics. 5, 4, p. 453-462 10 p.

Research output: Contribution to journalArticle

Histone Code
Renal Cell Carcinoma
Kidney Pelvis
Epigenomics
Genes
155 Citations (Scopus)

Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1

Volpert, O. V., Pili, R., Sikder, H. A., Nelius, T., Zaichuk, T., Morris, C., Shiflett, C. B., Devlin, M. K., Conant, K. & Alani, R. M., Dec 2002, In : Cancer Cell. 2, 6, p. 473-483 11 p.

Research output: Contribution to journalArticle

Thrombospondin 1
Embryonic Structures
Fibroblasts
Angiogenesis Inhibitors
Neutralizing Antibodies
72 Citations (Scopus)

Identification of ABR-215050 as lead second generation quinoline-3- carboxamide anti-angiogenic agent for the treatment of prostate cancer

Isaacs, J. T., Pili, R., Qian, D. Z., Dalrymple, S. L., Garrison, J. B., Kyprianou, N., Björk, A., Olsson, A. & Leanderson, T., Dec 1 2006, In : Prostate. 66, 16, p. 1768-1778 11 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Growth
Multiple Sclerosis
Neoplasms
Clinical Trials
77 Citations (Scopus)

Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target

Chong, C. R., Qian, D. Z., Pan, F., Wei, Y., Pili, R., Sullivan, D. J. & Liu, J. O., May 4 2006, In : Journal of Medicinal Chemistry. 49, 9, p. 2677-2680 4 p.

Research output: Contribution to journalArticle

Inosine Monophosphate
Endothelial cells
Oxidoreductases
Endothelial Cells
Cell proliferation
14 Citations (Scopus)

Immune parameters in a populatio of institutionalized elderly subjects: influence of depressive disorders and endocrinological correlations

Bartoloni, C., Guidi, L., Frasca, D., Antico, L., Pili, R., Cursi, F., Di Giovanni, A., Rumi, C., Menini, E., Carbonin, P., Doria, G. & Gambassi, G., 1991, In : Mechanisms of Ageing and Development. 60, 1, p. 1-12 12 p.

Research output: Contribution to journalArticle

Lymphocytes
Depressive Disorder
Hydrocortisone
Endorphins
Adrenocorticotropic Hormone
19 Citations (Scopus)

Immunomodulation by entinostat in renal cell carcinoma patients receiving high-dose interleukin 2: A multicenter, single-arm, phase I/II trial (NCI-CTEP#7870)

Pili, R., Quinn, D. I., Hammers, H. J., Monk, P., George, S., Dorff, T. B., Olencki, T., Shen, L., Orillion, A., Lamonica, D., Fragomeni, R. S., Szabo, Z., Hutson, A., Groman, A., Perkins, S., Piekarz, R. & Carducci, M. A., Dec 1 2017, In : Clinical Cancer Research. 23, 23, p. 7199-7208 10 p.

Research output: Contribution to journalArticle

Immunomodulation
Renal Cell Carcinoma
Interleukin-2
Confidence Intervals
Disease-Free Survival
15 Citations (Scopus)

Impact of cytoreductive nephrectomy on eligibility for systemic treatment and effects on survival: Are surgical complications or disease related factors responsible?

O'Malley, R. L., Brewer, K. A., Hayn, M. H., Kim, H. L., Underwood, W., Pili, R. & Schwaab, T., Sep 2011, In : Urology. 78, 3, p. 595-600 6 p.

Research output: Contribution to journalArticle

Nephrectomy
Survival
Renal Cell Carcinoma
Therapeutics
Intraoperative Complications
36 Citations (Scopus)

Impairment of lymphocyte activities in depressed aged subjects

Guidi, L., Bartoloni, C., Frasca, D., Antico, L., Pili, R., Cursi, F., Tempesta, E., Rumi, C., Menini, E., Carbonin, P., Doria, G. & Gambassi, G., 1991, In : Mechanisms of Ageing and Development. 60, 1, p. 13-24 12 p.

Research output: Contribution to journalArticle

Lymphocytes
Interleukin-2
Depression
Psychology
Depressive Disorder
35 Citations (Scopus)

Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells

Pettazzoni, P., Pizzimenti, S., Toaldo, C., Sotomayor, P., Tagliavacca, L., Liu, S., Wang, D., Minelli, R., Ellis, L., Atadja, P., Ciamporcero, E., Dianzani, M. U., Barrera, G. & Pili, R., Jan 15 2011, In : Free Radical Biology and Medicine. 50, 2, p. 313-322 10 p.

Research output: Contribution to journalArticle

Histone Deacetylase Inhibitors
Cell Cycle Checkpoints
Lipid Peroxidation
DNA Damage
Prostatic Neoplasms
7 Citations (Scopus)

Inhibition of Hsp90 augments docetaxel therapy in castrate resistant prostate cancer

Ku, S. Y., Lasorsa, E., Adelaiye, R., Ramakrishnan, S., Ellis, L. & Pili, R., Jul 29 2014, In : PLoS One. 9, 7, e103680.

Research output: Contribution to journalArticle

docetaxel
HSP90 Heat-Shock Proteins
Androgen Receptors
prostatic neoplasms
Prostatic Neoplasms
40 Citations (Scopus)

Initial contact and subsequent adhesion of human neutrophils or monocytes to human aortic endothelial cells releases an endothelial intracellular calcium store

Ziegelstein, R. C., Corda, S., Pili, R., Passaniti, A., Lefer, D., Zweier, J. L., Fraticelli, A. & Capogrossi, M. C., Oct 1994, In : Circulation. 90, 4 I, p. 1899-1907 9 p.

Research output: Contribution to journalArticle

Monocytes
Neutrophils
Leukocytes
Endothelial Cells
Calcium
29 Citations (Scopus)

Intravenous Bevacizumab Causes Regression of Choroidal Neovascularization Secondary to Diseases Other Than Age-related Macular Degeneration

Nguyen, Q. D., Shah, S. M., Hafiz, G., Do, D. V., Haller, J. A., Pili, R., Zimmer-Galler, I. E., Janjua, K., Symons, R. C. A. & Campochiaro, P. A., Feb 2008, In : American Journal of Ophthalmology. 145, 2

Research output: Contribution to journalArticle

Choroidal Neovascularization
Macular Degeneration
Fluorescein
Diabetic Retinopathy
Intravenous Infusions
66 Citations (Scopus)

In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of acidic fibroblast growth factor

Mühlhauser, J., Pili, R., Merrill, M. J., Maeda, H., Passaniti, A., Crystal, R. G. & Capogrossi, M. C., Nov 1995, In : Human Gene Therapy. 6, 11, p. 1457-1465 9 p.

Research output: Contribution to journalArticle

Fibroblast Growth Factor 1
Adenoviridae
Galactosidases
Angiogenesis Inducing Agents
Human Umbilical Vein Endothelial Cells
34 Citations (Scopus)

In vivo imaging of retinoic acid receptor β2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells

Qian, D. Z., Ren, M., Wei, Y., Wang, X., Van De Geijn, F., Rasmussen, C., Nakanishi, O., Sacchi, N. & Pili, R., Jun 15 2005, In : Prostate. 64, 1, p. 20-28 9 p.

Research output: Contribution to journalArticle

Retinoic Acid Receptors
Histone Deacetylase Inhibitors
Retinoids
Transcriptional Activation
Prostatic Neoplasms
9 Citations (Scopus)

Latent coagulation disorders evaluated by the assay of plasma thrombin-antithrombin III complexes in a large series of 'solid tumours'

Bartoloni, C., Guidi, L., Tricerri, A., Patriarca, F., Pili, R., Cursi, F., Canetta, M., Cappelli, A., Vangeli, M., Salvati, F. & Gambassi, G., 1992, In : Oncology. 49, 6, p. 426-430 5 p.

Research output: Contribution to journalArticle

Neoplasms
Blood Coagulation Disorders
Gastrointestinal Neoplasms
antithrombin III-protease complex
Non-Small Cell Lung Carcinoma
29 Citations (Scopus)

Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: Results of a phase I/II double-blinded, randomized study

Keizman, D., Zahurak, M., Sinibaldi, V., Carducci, M., Denmeade, S., Drake, C., Pili, R., Antonarakis, E. S., Hudock, S. & Eisenberger, M., Nov 1 2010, In : Clinical Cancer Research. 16, 21, p. 5269-5276 8 p.

Research output: Contribution to journalArticle

Prostate-Specific Antigen
Prostatic Neoplasms
Neutropenia
Population
Androgens
33 Citations (Scopus)

Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer

Armstrong, A. J., Häggman, M., Stadler, W. M., Gingrich, J. R., Assikis, V., Polikoff, J., Damber, J. E., Belkoff, L., Nordle, Ö., Forsberg, G., Carducci, M. A. & Pili, R., Dec 15 2013, In : Clinical Cancer Research. 19, 24, p. 6891-6901 11 p.

Research output: Contribution to journalArticle

Castration
Multicenter Studies
Prostatic Neoplasms
Biomarkers
Survival

Low-protein diet in cancer: Ready for prime time?

Pili, R. & Fontana, L., Jul 1 2018, In : Nature Reviews Endocrinology. 14, 7, p. 384-386 3 p.

Research output: Contribution to journalArticle

Protein-Restricted Diet
Diet
Diet Therapy
Neoplasms
Immune System
162 Citations (Scopus)

Lysosomal sequestration of sunitinib: A novel mechanism of drug resistance

Gotink, K. J., Broxterman, H. J., Labots, M., De Haas, R. R., Dekker, H., Honeywell, R. J., Rudek, M. A., Beerepoot, L. V., Musters, R. J., Jansen, G., Griffioen, A. W., Assaraf, Y. G., Pili, R., Peters, G. J. & Verheul, H. M. W., Dec 1 2011, In : Clinical Cancer Research. 17, 23, p. 7337-7346 10 p.

Research output: Contribution to journalArticle

Drug Resistance
sunitinib
Neoplasms
Cell Proliferation
Lysosomes
1 Citation (Scopus)

Major response to cyclophosphamide and prednisone in recurrent castration-resistant prostate cancer

Batty, N., Yarlagadda, N. & Pili, R., Aug 1 2013, In : JNCCN Journal of the National Comprehensive Cancer Network. 11, 8, p. 911-915 5 p.

Research output: Contribution to journalArticle

Castration
Prednisone
Cyclophosphamide
Prostatic Neoplasms
docetaxel
42 Citations (Scopus)

Marimastat in the treatment of patients with biochemically relapsed prostate cancer: A prospective randomized, double-blind, phase I/II trial

Rosenbaum, E., Zahurak, M., Sinibaldi, V., Carducci, M. A., Pili, R., Laufer, M., DeWeese, T. L. & Eisenberger, M. A., Jun 15 2005, In : Clinical Cancer Research. 11, 12, p. 4437-4443 7 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Prostate-Specific Antigen
Therapeutics
Matrix Metalloproteinase Inhibitors
Poisons
14 Citations (Scopus)

Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer

Gupta, N., Ustwani, O. A., Shen, L. & Pili, R., Feb 12 2014, In : OncoTargets and Therapy. 7, p. 223-234 12 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Pharmaceutical Preparations
Drug Approval
Phase III Clinical Trials
Phase II Clinical Trials
4 Citations (Scopus)

Mental disorders in obese patients with and without metabolic syndrome

Carpiniello, B., Pinna, F., Pili, R., Velluzzi, F. & Loviselli, A., Jan 1 2011, In : International Journal of Psychiatry in Medicine. 42, 4, p. 369-375 7 p.

Research output: Contribution to journalArticle

Mental Disorders
Abdominal Obesity
728 Citations (Scopus)

Methods in laboratory investigation: A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor

Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S. & Martin, G. R., 1992, In : Laboratory Investigation. 67, 4, p. 519-528 10 p.

Research output: Contribution to journalArticle

Angiogenesis Inhibitors
Fibroblast Growth Factors
Basement Membrane
Heparin
Gels
11 Citations (Scopus)

Mind the gap: Potential for rebounds during antiangiogenic treatment breaks

Ebos, J. M. L. & Pili, R., Jul 15 2012, In : Clinical Cancer Research. 18, 14, p. 3719-3721 3 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor A
Blood Vessels
Neoplasms
Appointments and Schedules
Endothelial Cells
8 Citations (Scopus)

Modeling spontaneous metastatic renal cell carcinoma (mRCC) in mice following nephrectomy

Tracz, A., Mastri, M., Lee, C. R., Pili, R. & Ebos, J. M. L., 2014, In : Journal of visualized experiments : JoVE. 86

Research output: Contribution to journalArticle

Nephrectomy
Renal Cell Carcinoma
Tumors
Cells
Disease Progression
16 Citations (Scopus)

Modeling the cost of management options for stage I nonseminomatous germ cell tumors: A decision tree analysis

Link, R. E., Allaf, M. E., Pili, R. & Kavoussi, L. R., 2005, In : Journal of Clinical Oncology. 23, 24, p. 5762-5773 12 p.

Research output: Contribution to journalArticle

Decision Trees
Decision Support Techniques
Costs and Cost Analysis
Drug Therapy
Nonseminomatous germ cell tumor
16 Citations (Scopus)

Modified synthesis and antiangiogenic activity of Linomide

Khan, S. R., Mhaka, A., Pili, R. & Isaacs, J. T., Feb 26 2001, In : Bioorganic and Medicinal Chemistry Letters. 11, 4, p. 451-452 2 p.

Research output: Contribution to journalArticle

Thermodynamic properties
Blood vessels
Microvessels
Blood Volume
Blood Vessels
5 Citations (Scopus)

Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer

Kalmuk, J., Folaron, M., Buchinger, J., Pili, R. & Seshadri, M., 2015, In : Oncotarget. 6, 27, p. 24376-24392 17 p.

Research output: Contribution to journalArticle

Multimodal Imaging
Blood Vessels
Prostatic Neoplasms
Neoplasms
Castration
5 Citations (Scopus)

Muscadine grape skin extract (MPX) in men with biochemically recurrent prostate cancer: A randomized, multicenter, placebo-controlled clinical trial

Paller, C. J., Zhou, X. C., Heath, E. I., Taplin, M. E., Mayer, T., Stein, M. N., Bubley, G. J., Pili, R., Hudson, T., Kakarla, R., Abbas, M. M., Anders, N. M., Dowling, D., King, S., Bruns, A. B., Wagner, W. D., Drake, C. G., Antonarakis, E. S., Eisenberger, M. A., Denmeade, S. R. & 3 others, Rudek, M. A., Rosner, G. L. & Carducci, M. A., Jan 15 2018, In : Clinical Cancer Research. 24, 2, p. 306-315 10 p.

Research output: Contribution to journalArticle

Controlled Clinical Trials
Vitis
Prostatic Neoplasms
Placebos
Skin
35 Citations (Scopus)

Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells

Minelli, R., Cavalli, R., Ellis, L., Pettazzoni, P., Trotta, F., Ciamporcero, E., Barrera, G., Fantozzi, R., Dianzani, C. & Pili, R., Nov 20 2012, In : European Journal of Pharmaceutical Sciences. 47, 4, p. 686-694 9 p.

Research output: Contribution to journalArticle

Camptothecin
Human Activities
Prostatic Neoplasms
Cyclodextrins
Neoplasms
43 Citations (Scopus)

NCCN task force report: Optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy

Hudes, G. R., Carducci, M. A., Choueiri, T. K., Esper, P., Jonasch, E., Kumar, R., Margolin, K. A., Michaelson, M. D., Motzer, R. J., Pili, R., Roethke, S. & Srinivas, S., 2011, In : JNCCN Journal of the National Comprehensive Cancer Network. 9, SUPPL. 1

Research output: Contribution to journalArticle

Molecular Targeted Therapy
Advisory Committees
Renal Cell Carcinoma
Therapeutics
32 Citations (Scopus)

Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: An illustration with the Supportive Care Needs Survey and the QLQ-C30

Snyder, C. F., Blackford, A. L., Brahmer, J. R., Carducci, M. A., Pili, R., Stearns, V., Wolff, A. C., Dy, S. M. & Wu, A. W., Aug 2010, In : Quality of Life Research. 19, 6, p. 837-845 9 p.

Research output: Contribution to journalArticle

Needs Assessment
ROC Curve
Area Under Curve
Aptitude
Fatigue
23 Citations (Scopus)

Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells

Pettazzoni, P., Ciamporcero, E., Medana, C., Pizzimenti, S., Dal Bello, F., Minero, V. G., Toaldo, C., Minelli, R., Uchida, K., Dianzani, M. U., Pili, R. & Barrera, G., Oct 15 2011, In : Free Radical Biology and Medicine. 51, 8, p. 1610-1618 9 p.

Research output: Contribution to journalArticle

Metabolism
Prostatic Neoplasms
Cells
4-hydroxy-2-nonenal
Detoxification